Quality and Technology
The mission of "Pharmasyntez" consists in the production of high-quality modern medicines available to patients, healthcare systems and partners.
The development of innovative medicines and put them into production is the main priority of the company. JSC "Pharmasyntez" is the only Russian pharmaceutical company, which is involved in the development of a new drug for the treatment of multidrug-resistant - PERCHLOZONE®. >>
Participation in the International forum as a lead partner of IPhEB&CPhI Russia has already become a good tradition for the company Pharmasyntez.
The Vialek group of companies President Alexander Alexandrov visited the Irkutsk plant of Pharmasyntez.
All business processes in the company comply with the strictest requirements, Pavel Lontsikh, the head of Irkutsk branch of Certification Association Russian Register, said during the ceremony.
February 8, 2016 the mayor of Irkutsk Dmitry Berdnikov made his official visit to the plant of JSC Pharmasyntez.
At the meeting the State President discussed the issues for the purpose of improvement of business climate with the core group of the Leaders Club, an informal association of small and medium business owners.